SEC Form 4 · accession 0001324863-26-000004
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tommy G Thompson
Director
Period of report
Jul 22, 2026
Accepted (ET)
Jul 23, 2026 · 4:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 8,480 | D | ||
| Common Stock | holding | — | — | — | 8,200 | I | by Trust | |
| Common Stock | holding | — | — | — | 5,800 | I | by Family LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F2,F4,F5 | $0.00 | Jul 22, 2026 | A | 380 | A | Jun 25, 2027 | — | Common Stock | 380 | 380 | D |
| Stock OptionF3,F4 | $527.07 | Jul 22, 2026 | A | 1,190 | A | Jun 25, 2027 | Jul 22, 2033 | Common Stock | 1,190 | 1,190 | D |
Explanation of responses
- F1Includes 880 shares of common stock issued on July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.
- F2Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F3Annual non-employee director award.
- F4Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
- F5Not applicable as restricted stock units do not have an expiration date.